Advantages of the avian model for human ovarian cancer (Review)
- Authors:
- Ana De Melo Bernardo
- Sólveig Thorsteinsdóttir
- Christine L. Mummery
-
Affiliations: Department of Anatomy and Embryology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands, Centre for Ecology, Evolution and Environmental Change, Department of Animal Biology, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal - Published online on: August 11, 2015 https://doi.org/10.3892/mco.2015.619
- Pages: 1191-1198
This article is mentioned in:
Abstract
Lowe KA, Chia VM, Taylor A, et al: An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol. 130:107–114. 2013. View Article : Google Scholar : PubMed/NCBI | |
Siegel R, Ma JM, Zou ZH and Jemal A: Cancer Statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI | |
Vaughan S, Coward JI, Bast RC, et al: Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 11:719–725. 2011. View Article : Google Scholar : PubMed/NCBI | |
Bharwani N, Reznek RH and Rockall AG: Ovarian cancer management: the role of imaging and diagnostic challenges. Eur J Radiol. 78:41–51. 2011. View Article : Google Scholar : PubMed/NCBI | |
Luvero D, Milani A and Ledermann JA: Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. Ther Adv Med Oncol. 6:229–239. 2014. View Article : Google Scholar : PubMed/NCBI | |
Menon U, Griffin M and Gentry-Maharaj A: Ovarian cancer screening - current status, future directions. Gynecol Oncol. 132:490–495. 2014. View Article : Google Scholar : PubMed/NCBI | |
Goff BA, Mandel LS, Drescher CW, et al: Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 109:221–227. 2007. View Article : Google Scholar : PubMed/NCBI | |
Bast RC, Hennessy B and Mills GB: The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 9:415–428. 2009. View Article : Google Scholar : PubMed/NCBI | |
Romero I and Bast RC Jr: Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology. 153:1593–1602. 2012. View Article : Google Scholar : PubMed/NCBI | |
King SM and Burdette JE: Evaluating the progenitor cells of ovarian cancer: analysis of current animal models. BMB Rep. 44:435–445. 2011. View Article : Google Scholar : PubMed/NCBI | |
RosalesNieves AE and Gonzalez-Reyes A: Genetics and mechanisms of ovarian cancer: parallels between Drosophila and humans. Semin Cell Dev Biol. 28:104–109. 2014. View Article : Google Scholar : PubMed/NCBI | |
Fong MY and Kakar SS: Ovarian cancer mouse models: a summary of current models and their limitations. J Ovarian Res. 2:122009. View Article : Google Scholar : PubMed/NCBI | |
Jacob F, Nixdorf S, Hacker NF and Heinzelmann-Schwarz VA: Reliable in vitro studies require appropriate ovarian cancer cell lines. J Ovarian Res. 7:602014. View Article : Google Scholar : PubMed/NCBI | |
Johnson PA and Giles JR: The hen as a model of ovarian cancer. Nat Rev Cancer. 13:432–436. 2013. View Article : Google Scholar : PubMed/NCBI | |
Vergara D, Merlot B, Lucot JP, et al: Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 291:59–66. 2010. View Article : Google Scholar : PubMed/NCBI | |
Naora H and Montell DJ: Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer. 5:355–366. 2005. View Article : Google Scholar : PubMed/NCBI | |
Fathalla MF: Incessant ovulation - a factor in ovarian neoplasia? Lancet. 2:1631971. View Article : Google Scholar : PubMed/NCBI | |
Erickson BK, Conner MG and Landen CN Jr: The role of the Fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 209:409–414. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fleming JS, Beaugie CR, Haviv I, ChenevixTrench G and Tan OL: Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol. 247:4–21. 2006. View Article : Google Scholar : PubMed/NCBI | |
Murdoch WJ and McDonnel AC: Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction. 123:743–750. 2002. View Article : Google Scholar : PubMed/NCBI | |
Murdoch WJ: Ovarian surface epithelium, ovulation and carcinogenesis. Biol Rev Camb Philos Soc. 71:529–543. 1996. View Article : Google Scholar : PubMed/NCBI | |
Auersperg N, Wong AS, Choi KC, Kang SK and Leung PC: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 22:255–288. 2001. View Article : Google Scholar : PubMed/NCBI | |
Maccio A and Madeddu C: Inflammation and ovarian cancer. Cytokine. 58:133–147. 2012. View Article : Google Scholar : PubMed/NCBI | |
Salehi F, Dunfield L, Phillips KP, Krewski D and Vanderhyden BC: Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev. 11:301–321. 2008. View Article : Google Scholar : PubMed/NCBI | |
De Sousa Damião R, Fujiyama Oshima CT, Stávale JN and Gonçalves WJ: Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries. Oncol Rep. 18:25–32. 2007.PubMed/NCBI | |
Moorman PG, Havrilesky LJ, Gierisch JM, et al: Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol. 31:4188–4198. 2013. View Article : Google Scholar : PubMed/NCBI | |
Auersperg N: Specific keynote: experimental models of epithelial ovarian carcinogenesis. Gynecol Oncol. 88:S47–51; discussion S52-55. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hakim AH, Turbov J and Rodriguez G: Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phila). 2:114–121. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kolwijck E, Span PN, Thomas CM, et al: Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer. Oncol Rep. 23:579–584. 2010.PubMed/NCBI | |
Walsh T, Casadei S, Lee MK, et al: Mutations in 12 genes for inherited ovarian, Fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA. 108:18032–18037. 2011. View Article : Google Scholar : PubMed/NCBI | |
Grant P, Sakellis C and Jacene HA: Gynecologic oncologic imaging with PET/CT. Semin Nucl Med. 44:461–478. 2014. View Article : Google Scholar : PubMed/NCBI | |
Chene G, PenaultLlorca F, Robin N, et al: Early detection of ovarian cancer: Tomorrow? A review. J Gynecol Obstet Biol Reprod (Paris). 42:5–11. 2013.(In French). View Article : Google Scholar : PubMed/NCBI | |
Lokshin AE: The quest for ovarian cancer screening biomarkers: Are we on the right road? Int J Gynecol Cancer. 22 Suppl 1:S35–S40. 2012. View Article : Google Scholar : PubMed/NCBI | |
Muggia F: Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol. 112:275–281. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kumar S, Mahdi H, Bryant C, et al: Clinical trials and progress with paclitaxel in ovarian cancer. Int J Womens Health. 2:411–427. 2010. View Article : Google Scholar : PubMed/NCBI | |
Huang RY, Chung VY and Thiery JP: Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Curr Drug Targets. 13:1649–1653. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kalachand R, Hennessy BT and Markman M: Molecular targeted therapy in ovarian cancer: what is on the horizon? Drugs. 71:947–967. 2011. View Article : Google Scholar : PubMed/NCBI | |
Syrios J, Banerjee S and Kaye SB: Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets - where are we now? Anticancer Res. 34:2069–2077. 2014.PubMed/NCBI | |
Itamochi H and Kigawa J: Clinical trials and future potential of targeted therapy for ovarian cancer. Int J Clin Oncol. 17:430–440. 2012. View Article : Google Scholar : PubMed/NCBI | |
Caponigro G and Sellers WR: Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov. 10:179–187. 2011. View Article : Google Scholar : PubMed/NCBI | |
Brumby AM and Richardson HE: Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer. 5:626–639. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hall CA, Wang R, Miao J, et al: Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res. 70:8517–8525. 2010. View Article : Google Scholar : PubMed/NCBI | |
House CD, Hernandez L and Annunziata CM: Recent technological advances in using mouse models to study ovarian cancer. Front Oncol. 4:262014. View Article : Google Scholar : PubMed/NCBI | |
Shaw TJ, Senterman MK, Dawson K, Crane CA and Vanderhyden BC: Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther. 10:1032–1042. 2004. View Article : Google Scholar : PubMed/NCBI | |
Fu X and Hoffman RM: Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res. 13:283–286. 1993.PubMed/NCBI | |
Roby KF, Taylor CC, Sweetwood JP, et al: Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis. 21:585–591. 2000. View Article : Google Scholar : PubMed/NCBI | |
Urzua U, Roby KF, Gangi LM, et al: Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets. J Cell Physiol. 206:594–602. 2006. View Article : Google Scholar : PubMed/NCBI | |
Orsulic S, Li Y, Soslow RA, et al: Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell. 1:53–62. 2002. View Article : Google Scholar : PubMed/NCBI | |
Xing D and Orsulic S: A mouse model for the molecular characterization of brca1-associated ovarian carcinoma. Cancer Res. 66:8949–8953. 2006. View Article : Google Scholar : PubMed/NCBI | |
FleskenNikitin A, Choi KC, Eng JP, Shmidt EN and Nikitin AY: Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63:3459–3463. 2003.PubMed/NCBI | |
Wu R, HendrixLucas N, Kuick R, et al: Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell. 11:321–333. 2007. View Article : Google Scholar : PubMed/NCBI | |
Fuller ES and Howell VM: Culture models to define key mediators of cancer matrix remodeling. Front Oncol. 4:572014. View Article : Google Scholar : PubMed/NCBI | |
Gillet JP, Calcagno AM, Varma S, et al: Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci USA. 108:18708–18713. 2011. View Article : Google Scholar : PubMed/NCBI | |
Yagi H, Yotsumoto F and Miyamoto S: Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Mol Cancer Ther. 7:3441–3451. 2008. View Article : Google Scholar : PubMed/NCBI | |
Sodek KL, Brown TJ and Ringuette MJ: Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration. BMC Cancer. 8:2232008. View Article : Google Scholar : PubMed/NCBI | |
Kenny HA, Krausz T, Yamada SD and Lengyel E: Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer. 121:1463–1472. 2007. View Article : Google Scholar : PubMed/NCBI | |
Yamada KM and Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell. 130:601–610. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lee JM, MhawechFauceglia P, Lee N, et al: A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest. 93:528–542. 2013. View Article : Google Scholar : PubMed/NCBI | |
White EA, Kenny HA and Lengyel E: Three-dimensional modeling of ovarian cancer. Adv Drug Deliv Rev 79–80. 184–192. 2014. View Article : Google Scholar | |
Pollock CG and Orosz SE: Avian reproductive anatomy, physiology and endocrinology. Vet Clin North Am Exot Anim Pract. 5:441–474. 2002. View Article : Google Scholar : PubMed/NCBI | |
Barnes MN, Berry WD, Straughn JM, et al: A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol Oncol. 87:57–63. 2002. View Article : Google Scholar : PubMed/NCBI | |
Carver DK, Barnes HJ, Anderson KE, et al: Reduction of ovarian and oviductal cancers in calorie-restricted laying chickens. Cancer Prev Res (Phila). 4:562–567. 2011. View Article : Google Scholar : PubMed/NCBI | |
Giles JR, Elkin RG, Trevino LS, et al: The restricted ovulator chicken: a unique animal model for investigating the etiology of ovarian cancer. Int J Gynecol Cancer. 20:738–744. 2010. View Article : Google Scholar : PubMed/NCBI | |
Seo HW, Rengaraj D, Choi JW, et al: The expression profile of apoptosis-related genes in the chicken as a human epithelial ovarian cancer model. Oncol Rep. 25:49–56. 2011.PubMed/NCBI | |
Havrilesky LJ, Gierisch JM, Moorman PG, et al: Oral contraceptive use for the primary prevention of ovarian cancer. Evid Rep Technol Assess (Full Rep). 212:1–514. 2013.PubMed/NCBI | |
Johnson PA and Giles JR: Use of genetic strains of chickens in studies of ovarian cancer. Poult Sci. 85:246–250. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hawkridge AM: The chicken model of spontaneous ovarian cancer. Proteomics Clin Appl. 8:689–699. 2014. View Article : Google Scholar : PubMed/NCBI | |
Fredrickson TN: Ovarian tumors of the hen. Environ Health Perspect. 73:35–51. 1987. View Article : Google Scholar : PubMed/NCBI | |
Trevino LS, Buckles EL and Johnson PA: Oral contraceptives decrease the prevalence of ovarian cancer in the hen. Cancer Prev Res (Phila). 5:343–349. 2012. View Article : Google Scholar : PubMed/NCBI | |
Barua A, Bitterman P, Abramowicz JS, et al: Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer. 19:531–539. 2009. View Article : Google Scholar : PubMed/NCBI | |
International Chicken Genome Sequencing Consortium, . Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature. 432:695–716. 2004. View Article : Google Scholar : PubMed/NCBI | |
Trevino LS, Giles JR, Wang W, Urick ME and Johnson PA: Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin? Horm Cancer. 1:177–186. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ansenberger K, Zhuge Y, Lagman JA, et al: E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol. 113:362–369. 2009. View Article : Google Scholar : PubMed/NCBI | |
Jackson E, Anderson K, Ashwell C, Petitte J and Mozdziak PE: CA 125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol. 104:192–198. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lim CH, Lim W, Jeong W, et al: Avian WNT4 in the female reproductive tracts: potential role of oviduct development and ovarian carcinogenesis. PLoS One. 8:e659352013. View Article : Google Scholar : PubMed/NCBI | |
Kim J, Coffey DM, Creighton CJ, et al: High-grade serous ovarian cancer arises from Fallopian tube in a mouse model. Proc Natl Acad Sci USA. 109:3921–3926. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kain KH, Miller JW, JonesParis CR, et al: The chick embryo as an expanding experimental model for cancer and cardiovascular research. Dev Dyn. 243:216–228. 2014. View Article : Google Scholar : PubMed/NCBI | |
Kurman RJ and Shih IeM: The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI | |
Davey MG and Tickle C: The chicken as a model for embryonic development. Cytogenet Genome Res. 117:231–239. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ayers KL, Sinclair AH and Smith CA: The molecular genetics of ovarian differentiation in the avian model. Sex Dev. 7:80–94. 2013. View Article : Google Scholar : PubMed/NCBI | |
Smith CA and Sinclair AH: Sex determination: insights from the chicken. Bioessays. 26:120–132. 2004. View Article : Google Scholar : PubMed/NCBI | |
Mittwoch U: Phenotypic manifestations during the development of the dominant and default gonads in mammals and birds. J Exp Zool. 281:466–471. 1998. View Article : Google Scholar : PubMed/NCBI | |
Mittwoch U: Sex determination. EMBO Rep. 14:588–592. 2013. View Article : Google Scholar : PubMed/NCBI | |
Roychoudhuri R, Putcha V and Moller H: Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Control. 17:655–662. 2006. View Article : Google Scholar : PubMed/NCBI | |
RodriguezLeon J, Rodriguez Esteban C, Marti M, et al: PITX2 regulates gonad morphogenesis. Proc Natl Acad Sci USA. 105:11242–11247. 2008. View Article : Google Scholar : PubMed/NCBI | |
Fung FK, Chan DW, Liu VW, et al: Increased expression of PITX2 transcription factor contributes to ovarian cancer progression. PLoS One. 7:e370762012. View Article : Google Scholar : PubMed/NCBI | |
Guioli S and Lovell-Badge R: PITX2 controls asymmetric gonadal development in both sexes of the chick and can rescue the degeneration of the right ovary. Development. 134:4199–4208. 2007. View Article : Google Scholar : PubMed/NCBI | |
Vela I, Morrissey C, Zhang X, et al: PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer. Clin Exp Metastasis. 31:199–211. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gobel G, Auer D, Gaugg I, et al: Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. Breast Cancer Res Treat. 130:109–117. 2011. View Article : Google Scholar : PubMed/NCBI | |
Wilting J and Hagedorn M: Left-right asymmetry in embryonic development and breast cancer: common molecular determinants? Curr Med Chem. 18:5519–5527. 2011. View Article : Google Scholar : PubMed/NCBI | |
Vandenberg LN and Levin M: A unified model for left-right asymmetry? Comparison and synthesis of molecular models of embryonic laterality. Dev Biol. 379:1–15. 2013. View Article : Google Scholar : PubMed/NCBI | |
Stern CD: The chick embryo - past, present and future as a model system in developmental biology. Mech Dev. 121:1011–1013. 2004. View Article : Google Scholar : PubMed/NCBI | |
SaukaSpengler T and Barembaum M: Gain- and loss-of-function approaches in the chick embryo. Methods Cell Biol. 87:237–256. 2008. View Article : Google Scholar : PubMed/NCBI | |
Intarapat S and Stern CD: Chick stem cells: current progress and future prospects. Stem Cell Res. 11:1378–1392. 2013. View Article : Google Scholar : PubMed/NCBI |